Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 6,240 | 5,260 | 6,429 | 6,338 | 6,854 |
| Gross Profit | 6,240 | 5,260 | 6,429 | 6,338 | 6,854 |
| Operating Expenses | 7,322 | 8,282 | 9,510 | 10,878 | 14,099 |
| Operating Income | -1,083 | -3,022 | -3,081 | -4,540 | -7,245 |
| Interest Expense | 14 | 10 | 15 | 15 | 3,121 |
| Other Income | 1,846 | 2,998 | 659 | 2,480 | -5,818 |
| Pre-tax Income | 749 | -34 | -2,438 | -2,076 | -16,184 |
| Net Income Continuous | 749 | -34 | -2,438 | -2,076 | -16,184 |
| Net Income | $749 | $-34 | $-2,438 | $-2,076 | $-16,184 |
| EPS Basic Total Ops | 3.21 | -0.21 | -15.02 | -12.01 | -132.13 |
| EPS Basic Continuous Ops | 5.28 | -0.21 | -15.70 | -13.47 | -133.72 |
| EPS Diluted Total Ops | 3.21 | -0.21 | -15.02 | -12.01 | -132.13 |
| EPS Diluted Continuous Ops | 5.28 | -0.21 | -15.70 | -13.47 | -133.72 |
| EBITDA(a) | $-970 | $-2,907 | $-2,965 | $-4,422 | $-6,983 |